Video

Less Than 50% of Candidates Receive Genetic Testing - Here's Why

Banu Arun, MD, explains the various reasons for the lack of genetic testing in appropriate candidates. This video was filmed December 12 at the 2019 San Antonio Breast Cancer Symposium.

Banu Arun, MD, explains the various reasons for the lack of genetic testing in appropriate candidates. This video was filmed December 12 at the 2019 San Antonio Breast Cancer Symposium.

Banu Arun, MD: Studies have shown that less than 50%—even less than 30%—of eligible patients actually are referred for genetic counseling and testing. We really don’t know the reasons for that, but I think it’s really multifactorial. It depends on education, patient perception, and maybe simply not having access to simple risk-assessment tools or genetic counselors.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Image credit: Dr_Microbe | stock.adobe.com